This article has been updated to clarify that the All of Us program still intends to use genotyping arrays on all participants to generate data for research and for returning non-health-related results.
NEW YORK – The National Institutes of Health's All of Us research program is working on an investigational device exemption (IDE) submission to the US Food and Drug Administration to return results to participants next year and is adjusting the mix of genomic technologies to generate data for its study cohort.